Investment ratings Just in case anyone missed this news on 14th September, Investec issued an 'add' notice with a target price for AMS of 245p. Numis, meanwhile, toned down its investment advice to 'hold' with a target of 235p. While writing this, I am sure that I hear AMS staff whistling happily as they pack and stack high the boxes of sutures ready for the US market. Chart trend line holding well after some inevitable profit taking. BB20
Re: Interims Update from N1 Singer on Research Tree:"AMS interims are as expected, with revenues ahead but profits in line. Revenues were up 20% YoY and Adj EPS +14%, so a strong H1 performance, aided by currency, but showing good progress with LiquiBand in the US and the new Fix8 device in particular. Cash was also very strong at £41.1m, but there is still no sign of any acquisitions. The DPS has been hiked by 20% perhaps acknowledging this, although the cash cost of this remains modest. The shares remain very highly rated on 31.3x P/E to Dec-16, falling to 29.2x FY17."
Re: Interims BB20 - Solid results, loads of cash, share price up. Yes, I agree, 250p beforeby Chrismas now looks distinctly on the cards. AMS, in my books, is the soundestCompany with the soundest Management I have ever been invested in.I am also beginning to like APH, where management is on the ball, where management talks no nonsense, where honest progress is being made in expanding sales in the virtual recession proof global healthcare market.Cheers,,ws
Interims Interims are out and show our company to be in robust health with sales steadily expanding (galloping onwards in the case of branded distributed goods). Revenues and profits have risen impressively and cash in hand is up 81%. Sutures out of the starting blocks in the US and initial sales yielding positive feedback. The market clearly likes the results but a rise of over 7p is bound to cause some profit taking later today. I stand by my prediction of 250p by Christmas.BB20
Re: FAO: BB20 / CHT not sure! BB20 - Now not sure about CHT, see my message there, take care. ws
SP holding (WS) Hi WS.The SP trajectory of the last few days suggests to me that people expect 'more of the same' (or perhaps even better than that) on the 14th. Most may be reluctant, therefore, to sell now with only eight trading days to results, which is helping to keep the SP aloft. However, as you and I have already agreed, a retracement of some sort is very likely to come in the nearness of time. "Buy on the rumour, sell on the fact" points to the 14th as the most likely date for a pronounced pull back, as profit-talking starts kicking in. UNLESS, that is, (a) the results turn out to be stellar; or (b) the near term outlook for market penetration and increased sales is hugely promising; or (c) where we are regaled with reports of both (a) and (b). I imagine scenario (c) would cause a few pence to be added to the SP and delay the anticipated pull back by at least a few days. Needless to say, all of this is conjectural, even if based on trends and patterns of the past. Whatever pull back occurs will be unlikely in my opinion to change the direction and momentum for very long (unless, of course, the report is badly disappointing). Thanks for the thumbs up on CHT. I'll take a look. I have both QFI and RTHM on my radar and am readjusting my portfolio with a view to picking up a few more of both. BB20